Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73:411–8.
Article CAS PubMed Google Scholar
Tanaka A, Tomiyama H, Maruhashi T, Matsuzawa Y, Miyoshi T, Kabutoya T, et al. Physiological diagnostic criteria for vascular failure. Hypertension. 2018;72:1060–71.
Article CAS PubMed Google Scholar
Maruhashi T, Kajikawa M, Kishimoto S, Yamaji T, Harada T, Hashimoto Y, et al. Seasonal variations in endothelium-dependent flow-mediated vasodilation and endothelium-independent nitroglycerine-induced vasodilation. Hypertens Res. 2024;47:910–20.
Article CAS PubMed Google Scholar
Cicero AFG, Pirro M, Watts GF, Mikhailidis DP, Banach M, Sahebkar A. Effects of allopurinol on endothelial function: a systematic review and meta-analysis of randomized placebo-controlled trials. Drugs. 2018;78:99–109.
Article CAS PubMed Google Scholar
Kurajoh M, Fukumoto S, Akari S, Murase T, Nakamura T, Ihara Y, et al. Association of plasma xanthine oxidoreductase activity with vascular endothelial function independent of serum uric acid level: MedCity21 health examination registry. Int J Cardiol Heart Vasc 2023;48:101264.
PubMed PubMed Central Google Scholar
Tomiyama H, Higashi Y, Takase B, Node K, Sata M, Inoue T, et al. Relationships among hyperuricemia, metabolic syndrome, and endothelial function. Am J Hypertens. 2011;24:770–4.
Article CAS PubMed Google Scholar
Maruhashi T, Nakashima A, Soga J, Fujimura N, Idei N, Mikami S, et al. Hyperuricemia is independently associated with endothelial dysfunction in postmenopausal women but not in premenopausal women. BMJ Open. 2013;3:e003659.
Article PubMed PubMed Central Google Scholar
Tanaka A, Kawaguchi A, Tomiyama H, Ishizu T, Matsumoto C, Higashi Y, et al. Cross-sectional and longitudinal associations between serum uric acid and endothelial function in subjects with treated hypertension. Int J Cardiol. 2018;272:308–13.
Kishimoto S, Oki K, Maruhashi T, Kajikawa M, Mizobuchi A, Harada T, et al. KCNJ5 mutation is a predictor for recovery of endothelial function after adrenalectomy in patients with aldosterone-producing adenoma. Hypertens Res. 2023;46:2213–27.
Article CAS PubMed Google Scholar
Okawa K, Sogo M, Morimoto T, Tsushima R, Sudo Y, Saito E, et al. Relationship between endothelial dysfunction and the outcomes after atrial fibrillation ablation. J Am Heart Assoc. 2023;12:028482.
Shin SY, Na JO, Lim HE, Choi CU, Choi JI, Kim SH, et al. Improved endothelial function in patients with atrial fibrillation through maintenance of sinus rhythm by successful catheter ablation. J Cardiovasc Electrophysiol. 2011;22:376–82.
Behnoush AH, Khalaji A, Bahiraie P, Alehossein P, Shobeiri P, Peisepar M, et al. Endocan as a marker of endothelial dysfunction in hypertension: a systematic review and meta-analysis. Hypertens Res. 2023;46:2388–99.
Article CAS PubMed Google Scholar
Hirooka Y. How can endocan be used as a specific biomarker of endothelial dysfunction in hypertension? Hypertens Res. 2024;47:794–5.
Maruhashi T, Higashi Y. Pathophysiological association between diabetes mellitus and endothelial dysfunction. Antioxidants. 2021;10:1306.
Article CAS PubMed PubMed Central Google Scholar
Kim H, Choi CU, Rhew K, Park J, Lim Y, Kim MG, et al. Comparative effects of glucose-lowering agents on endothelial function and arterial stiffness in patients with type 2 diabetes: a network meta-analysis. Atherosclerosis. 2024;391:117490.
Article CAS PubMed Google Scholar
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.
Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874–2071.
Article CAS PubMed Google Scholar
Motobe K, Tomiyama H, Koji Y, Yambe M, Gulinisa Z, Arai T, et al. Cut-off value of the ankle-brachial pressure index at which the accuracy of brachial-ankle pulse wave velocity measurement is diminished. Circ J. 2005;69:55–60.
Ishida A, Taira H, Shinzato T, Ohya Y. Association between visceral fat mass and arterial stiffness among community-based screening participants. Hypertens Res. 2023;46:2488–2496.
Article CAS PubMed Google Scholar
Alhalimi TA, Wang T, Meyer ML, Tanaka H. Effects of body positions on arterial stiffness as assessed by pulse wave velocity. J Hypertens. 2023;41:971–8.
Yatsu S, Kasai T, Naito R, Matsumoto H, Murata A, Shitara J, et al. Impact of sleep-disordered breathing on overnight changes in arterial stiffness in patients with acute heart failure. Hypertens Res. 2024;47:342–51.
Clark CE, Warren FC, Boddy K, McDonagh S, Moore SF, Goddard J, et al. Associations between systolic interarm differences in blood pressure and cardiovascular disease outcomes and mortality: individual participant data meta-analysis, development and validation of a prognostic algorithm: the INTERPRESS-IPD collaboration. Hypertension. 2021;77:650–61.
Article CAS PubMed Google Scholar
Shiina K, Takata Y, Nakano H, Fujii M, Iwasaki Y, Kumai K, et al. Moderate to severe obstructive sleep apnea is independently associated with inter-arm systolic blood pressure difference: Tokyo Sleep Heart Study. J Hypertens. 2022;40:318–26.
Article CAS PubMed Google Scholar
Tomiyama H, Imai T, Shiina K, Higashi Y, Nakano H, Takahashi T, et al. Lifelong heterogeneous contribution of cardiovascular risk factors to slow and fast progression of arterial stiffness. Hypertension. 2023;80:2159–68.
Article CAS PubMed Google Scholar
Miyagi T, Ishida A, Shinzato T, Ohya Y. Arterial stiffness is associated with small vessel disease irrespective of blood pressure in stroke-free individuals. Stroke. 2023;54:2814–21.
Article CAS PubMed Google Scholar
Zheng H, Wu S, Liu X, Qiu G, Chen S, Wu Y, et al. Association between arterial stiffness and new-onset heart failure: the Kailuan study. Arterioscler Thromb Vasc Biol. 2023;43:e104–e111.
Article CAS PubMed Google Scholar
Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, et al. Life’s essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146:e18–e43.
Article PubMed PubMed Central Google Scholar
Wu S, Wu Z, Yu D, Chen S, Wang A, Wang A, et al. Life’s essential 8 and risk of stroke: a prospective community-based study. Stroke. 2023;54:2369–79.
Watanabe Y. Fundamentals of utilizing upstroke time and percentage mean arterial pressure of ankle pulse volume recording as cardiovascular indexes. Hypertens Res. 2024;47:2091–93.
Maruhashi T, Kajikawa M, Kishimoto S, Hashimoto H, Takaeko Y, Yamaji T, et al. Upstroke time is a useful vascular marker for detecting patients with coronary artery disease among subjects with normal Ankle-Brachial Index. J Am Heart Assoc. 2020;9:017139.
Maruhashi T, Kajikawa M, Kishimoto S, Yamaji T, Harada T, Hashimoto Y, et al. Percentage of mean arterial pressure as a marker of atherosclerosis for detecting patients with coronary artery disease. Hypertens Res. 2024;47:281–90.
Maruhashi T, Kajikawa M, Kishimoto S, Yamaji T, Harada T, Hashimoto Y, et al. Upstroke time is a more useful marker of atherosclerosis than percentage of mean arterial pressure for detecting coronary artery disease in subjects with a normal ankle-brachial index. Hypertens Res. 2024;47:2009–2018.
Comments (0)